• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

cereblon:一种对免疫调节药物的多种功能以及细胞代谢和疾病发生至关重要的蛋白质。

Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation.

机构信息

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University/Jiangsu Province Hospital, 300 Guangzhou Road, Nanjing 210029, China.

出版信息

J Immunol Res. 2017;2017:9130608. doi: 10.1155/2017/9130608. Epub 2017 Aug 15.

DOI:10.1155/2017/9130608
PMID:28894755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5574216/
Abstract

It is well known that cereblon is a key protein in autosomal recessive nonsyndromic mental retardation. Studies have reported that it has an intermediary role in helping immunomodulatory drugs perform their immunomodulatory and tumoricidal effects. In addition, cereblon also regulates the expression, assembly, and activities of other special proteins related to cell proliferation and metabolism, resulting in the occurrence and development of metabolic diseases. This review details the multiple functions of cereblon and the underlying mechanisms. We also put forward some unsolved problems, including the intrinsic mechanism of cereblon function and the possible regulatory mechanisms of its expression.

摘要

众所周知,cereblon 是常染色体隐性非综合征性智力低下的关键蛋白。研究表明,它在帮助免疫调节药物发挥其免疫调节和杀肿瘤作用方面发挥了中介作用。此外,cereblon 还调节与细胞增殖和代谢相关的其他特殊蛋白的表达、组装和活性,导致代谢性疾病的发生和发展。本综述详细介绍了 cereblon 的多种功能及其潜在机制。我们还提出了一些尚未解决的问题,包括 cereblon 功能的内在机制及其表达的可能调节机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7429/5574216/d4641865347d/JIR2017-9130608.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7429/5574216/d4641865347d/JIR2017-9130608.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7429/5574216/d4641865347d/JIR2017-9130608.001.jpg

相似文献

1
Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation. cereblon:一种对免疫调节药物的多种功能以及细胞代谢和疾病发生至关重要的蛋白质。
J Immunol Res. 2017;2017:9130608. doi: 10.1155/2017/9130608. Epub 2017 Aug 15.
2
The evolving tale of immunomodulatory drugs and cereblon.免疫调节药物与脑啡肽的演变故事。
Clin Pharmacol Ther. 2014 Nov;96(5):538-41. doi: 10.1038/clpt.2014.168. Epub 2014 Aug 21.
3
Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival.大脑神经酰胺结合蛋白阿贡纳乌特2的表达对多发性骨髓瘤细胞的生长和存活起着重要作用。
BMC Cancer. 2016 May 3;16:297. doi: 10.1186/s12885-016-2331-0.
4
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.免疫调节药物破坏 cereblon-CD147-MCT1 轴发挥抗肿瘤活性和致畸性。
Nat Med. 2016 Jul;22(7):735-43. doi: 10.1038/nm.4128. Epub 2016 Jun 13.
5
Do baseline Cereblon gene expression and IL-6 receptor expression determine the response to thalidomide-dexamethasone treatment in multiple myeloma patients?基线 Cereblon 基因表达和白介素-6 受体表达是否决定多发性骨髓瘤患者对沙利度胺-地塞米松治疗的反应?
Eur J Haematol. 2014 Jan;92(1):13-8. doi: 10.1111/ejh.12207. Epub 2013 Oct 29.
6
[Thalidomide, cereblon and multiple myeloma].[沙利度胺、脑啡肽和多发性骨髓瘤]
Nihon Rinsho. 2015 Jan;73(1):149-55.
7
Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression.对于伴有脑啡肽表达的老年多发性骨髓瘤患者,基于沙利度胺的诱导方案与基于硼替佐米的方案疗效相当。
Ann Hematol. 2016 Oct;95(10):1645-51. doi: 10.1007/s00277-016-2743-6. Epub 2016 Jul 1.
8
Cereblon binding molecules in multiple myeloma.多发性骨髓瘤中的脑啡肽结合分子
Blood Rev. 2015 Sep;29(5):329-34. doi: 10.1016/j.blre.2015.03.003. Epub 2015 Mar 27.
9
Zeroing in on cereblon.聚焦于 Cereblon 蛋白。
Eur J Haematol. 2015 Jul;95(1):1-2. doi: 10.1111/ejh.12525. Epub 2015 Mar 16.
10
Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment.β-连环蛋白编码基因内的多态性影响多发性骨髓瘤的发展和治疗。
Leuk Res. 2015 Dec;39(12):1462-6. doi: 10.1016/j.leukres.2015.10.007. Epub 2015 Oct 19.

引用本文的文献

1
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma.在多发性骨髓瘤细胞治疗背景下,通过调节E3连接酶底物靶向降解IKZF1和IKZF3
Biomark Res. 2025 Aug 15;13(1):105. doi: 10.1186/s40364-025-00825-8.
2
Serum Cereblon (CRBN) Levels Predict Long Term Post- Lenalidomide-Dexamethasone Survival in Multiple Myeloma (MM) Patients and Correlate with Disease Characteristics.血清 Cereblon(CRBN)水平可预测多发性骨髓瘤(MM)患者接受来那度胺 - 地塞米松治疗后的长期生存率,并与疾病特征相关。
Int J Mol Sci. 2025 Jun 30;26(13):6341. doi: 10.3390/ijms26136341.
3

本文引用的文献

1
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM).IKZF1 表达是接受来那度胺和强化化疗治疗的初诊标准风险多发性骨髓瘤的预后标志物:德国骨髓瘤研究组(DSMM)的一项研究。
Leukemia. 2017 Jun;31(6):1363-1367. doi: 10.1038/leu.2016.384. Epub 2016 Dec 26.
2
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide.IKZF1/3蛋白高表达是接受来那度胺治疗的复发/难治性多发性骨髓瘤患者生存的有利预后因素。
J Hematol Oncol. 2016 Nov 21;9(1):123. doi: 10.1186/s13045-016-0354-2.
3
Advancing brain tumor therapy: unveiling the potential of PROTACs for targeted protein degradation.
推进脑肿瘤治疗:揭示PROTACs靶向蛋白降解的潜力。
Cytotechnology. 2025 Apr;77(2):54. doi: 10.1007/s10616-025-00716-8. Epub 2025 Jan 31.
4
Exploration of degrons and their ability to mediate targeted protein degradation.降解结构域及其介导靶向蛋白质降解能力的探索。
RSC Med Chem. 2025 Jan 1. doi: 10.1039/d4md00787e.
5
Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors.利用分子降解剂靶向 EGFR 作为克服 EGFR 抑制剂耐药性的一种有前途的策略。
Future Med Chem. 2024;16(18):1923-1944. doi: 10.1080/17568919.2024.2389764. Epub 2024 Aug 29.
6
Cereblon deficiency ameliorates carbon tetrachloride-induced acute hepatotoxicity in HepG2 cells by suppressing MAPK-mediated apoptosis.Cereblon 缺乏通过抑制 MAPK 介导的细胞凋亡改善四氯化碳诱导的 HepG2 细胞急性肝毒性。
Front Immunol. 2024 Jul 30;15:1457636. doi: 10.3389/fimmu.2024.1457636. eCollection 2024.
7
Lenalidomide and dexamethasone for Rosai-Dorfman disease: a single arm, single center, prospective phase 2 study.来那度胺和地塞米松治疗罗萨伊-多夫曼病:一项单臂、单中心、前瞻性2期研究。
EClinicalMedicine. 2024 Jun 21;73:102685. doi: 10.1016/j.eclinm.2024.102685. eCollection 2024 Jul.
8
Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma.靶向BRD9和IKZF3的协同作用作为多发性骨髓瘤的一种治疗策略
Cancers (Basel). 2024 Mar 28;16(7):1319. doi: 10.3390/cancers16071319.
9
Pan-cancer analysis reveals the prognostic and immunologic roles of cereblon and its significance for PROTAC design.泛癌分析揭示了cereblon的预后和免疫作用及其对PROTAC设计的意义。
Heliyon. 2023 May 29;9(6):e16644. doi: 10.1016/j.heliyon.2023.e16644. eCollection 2023 Jun.
10
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.新一代 IMiDs 类药物治疗神经炎症和神经退行性疾病。
Biomolecules. 2023 Apr 26;13(5):747. doi: 10.3390/biom13050747.
Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma.
脑啡肽在多发性骨髓瘤患者中的预后意义
Clin Lymphoma Myeloma Leuk. 2016 Nov;16(11):610-615. doi: 10.1016/j.clml.2016.08.007. Epub 2016 Aug 10.
4
Cereblon negatively regulates TLR4 signaling through the attenuation of ubiquitination of TRAF6.脑啡肽通过减弱肿瘤坏死因子受体相关因子6(TRAF6)的泛素化来负向调节Toll样受体4(TLR4)信号通路。
Cell Death Dis. 2016 Jul 28;7(7):e2313. doi: 10.1038/cddis.2016.226.
5
Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs.作为免疫调节药物分子靶点的 Cereblon 及其下游底物。
Int J Hematol. 2016 Sep;104(3):293-9. doi: 10.1007/s12185-016-2073-4. Epub 2016 Jul 26.
6
Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation.cereblon对编码Kv1.3钾通道的Kcna3进行表观遗传调控,有助于调节CD4+ T细胞的激活。
Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8771-6. doi: 10.1073/pnas.1502166113. Epub 2016 Jul 20.
7
Cereblon in health and disease.健康与疾病中的 Cereblon。
Pflugers Arch. 2016 Aug;468(8):1299-309. doi: 10.1007/s00424-016-1854-1. Epub 2016 Jun 24.
8
A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.一种新型的cereblon 调节剂将 GSPT1 招募到 CRL4(CRBN)泛素连接酶。
Nature. 2016 Jul 14;535(7611):252-7. doi: 10.1038/nature18611. Epub 2016 Jun 22.
9
Nuclear cereblon modulates transcriptional activity of Ikaros and regulates its downstream target, enkephalin, in human neuroblastoma cells.在人类神经母细胞瘤细胞中,细胞核内的脑啡肽调节IKAROS的转录活性并调控其下游靶点脑啡肽。
Biochem Biophys Res Commun. 2016 Aug 26;477(3):388-94. doi: 10.1016/j.bbrc.2016.06.091. Epub 2016 Jun 18.
10
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.免疫调节药物破坏 cereblon-CD147-MCT1 轴发挥抗肿瘤活性和致畸性。
Nat Med. 2016 Jul;22(7):735-43. doi: 10.1038/nm.4128. Epub 2016 Jun 13.